United States · FDA National Drug Code directory
Lumason
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0270-7097_47b0f2df-0b6c-a221-750d-763d5ece665b
- Product NDC
- 0270-7097
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- SULFUR HEXAFLUORIDE
- Labeler
- BRACCO DIAGNOSTICS INC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210401
- Source listing expiry
- 20261231
Source-listed ingredients
- SULFUR HEXAFLUORIDE — 60.7 mg/mg
- DISTEAROYLPHOSPHATIDYLCHOLINE, DL- — .19 mg/mg
- SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) — .19 mg/mg
These values do not establish equivalence or a dose recommendation.
Packages
- 20 VIAL in 1 BOX (0270-7097-08) / 25 mg in 1 VIAL · 0270-7097-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →